Versican G3 domain promotes blood coagulation through suppressing the activity of tissue factor pathway inhibitor-1. (Q40326044)

19 September 2017

Versican G3 domain promotes blood coagulation through suppressing the activity of tissue factor pathway inhibitor-1. (English)

1 reference

19 September 2017

Peng-Sheng Zheng

1

1 reference

19 September 2017

Marciano Reis

2

1 reference

19 September 2017

Cathy Sparling

3

1 reference

19 September 2017

Daniel Y Lee

4

1 reference

19 September 2017

David P La Pierre

5

1 reference

19 September 2017

Chung-Kwun Amy Wong

6

1 reference

19 September 2017

Zhaoqun Deng

7

1 reference

19 September 2017

Shireen Kahai

8

1 reference

19 September 2017

Jianping Wen

9

1 reference

19 September 2017

Burton B Yang

10

1 reference

19 September 2017

language of work or name

English

0 references

publication date

23 January 2006

1 reference

Journal of Biological Chemistry

19 September 2017

1 reference

19 September 2017

281

1 reference

19 September 2017

12

1 reference

19 September 2017

8175-8182

1 reference

Aortic endothelial cells synthesize a large chondroitin sulphate proteoglycan capable of binding to hyaluronate

19 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

Chondroitin sulfate anticoagulant activity is linked to water transfer: relevance to proteoglycan structure in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

A system for stable expression of short interfering RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

Cleavage of the carboxyl tail from the G3 domain of aggrecan but not versican and identification of the amino acids involved in the degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

beta 1-Integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

Versican/PG-M G3 domain promotes tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

The G3 domain of versican enhances cell proliferation via epidermial growth factor-like motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

Comparison of deposits of versican, biglycan and decorin in saphenous vein and internal thoracic, radial and coronary arteries: correlation to patency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

Proteoglycans in atherosclerosis and restenosis: key roles for versican

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

A novel missense mutation shows that GPIbbeta has a dual role in controlling the processing and stability of the platelet GPIb-IX adhesion receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

Low-density lipoprotein binding affinity of arterial chondroitin sulfate proteoglycan variants modulates cholesteryl ester accumulation in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

G3 domains of aggrecan and PG-M/versican form intermolecular disulfide bonds that stabilize cell-matrix interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M509182200

21 January 2018

Identifiers

DOI

10.1074/JBC.M509182200

1 reference

19 September 2017

1 reference